Tratamiento de la Enfermedad de Meniere

Modificaciones Dietéticas y de Estilo de Vida

• La American Academy of Otolaryngology-Head and Neck Surgery recomienda una restricción de sodio (1500-2300 mg diarios) para reducir la acumulación de líquido en el oído interno 1, 2
• La limitación del consumo de alcohol es recomendada, ya que puede desencadenar ataques en algunos pacientes 1, 2
• La limitación de la ingesta de cafeína es recomendada, ya que puede ser un desencadenante para ciertos pacientes 1, 2
• La identificación y manejo de alergias es importante, ya que pueden contribuir a los síntomas en hasta el 30% de los pacientes 3
• El manejo adecuado del estrés mediante técnicas de relajación, ejercicio regular y sueño adecuado es recomendado 3, 2
• La American Academy of Otolaryngology-Head and Neck Surgery sugiere mantener un diario de síntomas para identificar desencadenantes personales 1, 2

Farmacoterapia para Ataques Agudos de Vértigo

• La American Academy of Otolaryngology-Head and Neck Surgery recomienda ofrecer un curso limitado de supresores vestibulares únicamente durante los ataques agudos de vértigo 3
• La opción farmacológica para ataques agudos incluye antihistamínicos (como dimenhidrinato, meclizina) 1
• La opción farmacológica para ataques agudos también incluye benzodiazepinas para aliviar la ansiedad asociada (con precaución debido al riesgo de dependencia) 3

Terapia de Mantenimiento

• La American Academy of Otolaryngology-Head and Neck Surgery recomienda diuréticos para alterar el balance electrolítico en el endolinfa, reduciendo su volumen 1, 4
• La betahistina es un análogo de la histamina que aumenta la vasodilatación al oído interno y puede ser utilizada como terapia de mantenimiento 1, 4

Terapias Intratimpánicas

• La American Academy of Otolaryngology-Head and Neck Surgery sugiere que se pueden ofrecer esteroides intratimpánicos a pacientes con enfermedad de Meniere activa que no responden al tratamiento no invasivo 5
• La gentamicina intratimpánica es una opción para pacientes con vértigo persistente 1, 5

Procedimientos Quirúrgicos

• La American Academy of Otolaryngology-Head and Neck Surgery considera opciones quirúrgicas para casos refractarios a tratamiento médico, incluyendo procedimientos conservadores de la audición y procedimientos ablativos 1

Consideraciones Importantes

• La American Academy of Otolaryngology-Head and Neck Surgery no recomienda la terapia de presión positiva (dispositivo Meniett) para pacientes con enfermedad de Meniere 5
• La rehabilitación vestibular/terapia física no es recomendada para el manejo de ataques agudos de vértigo, pero puede ser útil para el manejo del desequilibrio crónico entre ataques 5, 1

Advertencias y Precauciones

• La American Academy of Otolaryngology-Head and Neck Surgery advierte que no existe una cura definitiva para la enfermedad de Meniere 1
• La evidencia científica para muchas intervenciones es limitada, especialmente para las modificaciones dietéticas 5, 4
• Se debe considerar comorbilidades que puedan contraindicar ciertos medicamentos (enfermedad renal o cardíaca, asma) 5, 4
• Se debe tener precaución con el uso prolongado de benzodiazepinas debido al riesgo de dependencia 3

Management of Meniere's Disease

Treatment Approach

• The American Academy of Otolaryngology-Head and Neck Surgery recommends a stepwise approach to treating Meniere's disease, starting with dietary and lifestyle modifications, followed by pharmacotherapy with diuretics and/or betahistine, and progressing to more invasive treatments like intratympanic steroids only if necessary 6
• Diuretics can be used to modify the electrolyte balance in the endolymph and reduce its volume, and betahistine (an analogue of histamine) can increase vasodilation to the inner ear, both of which can reduce symptoms or prevent attacks 6

Second-Line Treatments

• Intratympanic steroids can be used for patients with active disease who do not respond to non-invasive treatment, with benefits including better control of vertigo, improved quality of life, and faster return to work 6, 7
• However, there are also risks associated with intratympanic steroids, including hearing loss, tympanic membrane perforation, and persistent imbalance 7

Follow-Up

• Systematic documentation of the resolution, improvement, or worsening of vertigo, tinnitus, and hearing loss after treatment is recommended, along with regular evaluation of the impact on quality of life 7
• Treatment should be adjusted based on the evolution of symptoms 6

Meniere's Disease Management

Pharmacotherapy and Intratympanic Therapies

• The American Academy of Otolaryngology-Head and Neck Surgery guideline cannot make a definitive recommendation for betahistine due to questionable efficacy based on recent evidence, including the BEMED trial which found no significant difference between betahistine and placebo in reducing vertigo attacks 8
• Intratympanic steroids may be offered to patients with active Meniere's disease not responsive to non-invasive treatments, with studies showing 85-90% improvement in vertigo symptoms compared to 57-80% with conventional therapy 9
• Intratympanic gentamicin is effective for vertigo control in patients who have failed conservative therapies, with a complete vertigo control rate of approximately 73.6% across studies, and a risk of hearing loss varying by administration method 10

Surgical Options

• Labyrinthectomy may be offered to patients with active Meniere's disease who have failed less definitive therapy and have non-usable hearing 10

Treatments Not Recommended

• The American Academy of Otolaryngology-Head and Neck Surgery recommends against positive pressure therapy (Meniett device) based on systematic reviews showing no significant difference compared to placebo 8

Alternatives to Betahistine for Ménière's Disease

Introduction to Treatment Alternatives

• The American Academy of Otolaryngology-Head and Neck Surgery recommends diuretics as an option for maintenance therapy based on observational studies and Cochrane reviews, with moderate evidence quality 11
• Diuretics modify electrolyte balance in the endolymph and reduce its volume, serving as a primary alternative to betahistine for maintenance therapy 11, 12

Pharmacotherapy for Maintenance

• The American Academy of Otolaryngology-Head and Neck Surgery recommends offering a limited course of vestibular suppressants only during acute episodes 11, 12

Intratympanic Therapies for Refractory Disease

• The American Academy of Otolaryngology-Head and Neck Surgery recommends offering intratympanic gentamicin to patients not responsive to non-ablative therapy 12
• Intratympanic steroids can offer 85-90% improvement in vertigo symptoms, with improved quality of life and faster return to work, although risks include hearing loss and tympanic membrane perforation 11

Vestibular Rehabilitation

• The American Academy of Otolaryngology-Head and Neck Surgery recommends offering vestibular rehabilitation for chronic imbalance between attacks or following ablative therapy, with benefits including improved symptom control and reduced fall risk 11, 12

Treatments NOT Recommended

• The American Academy of Otolaryngology-Head and Neck Surgery recommends against positive pressure therapy (Meniett device) based on systematic reviews showing no significant difference compared to placebo 12

Critical Monitoring Requirements

• The American Academy of Otolaryngology-Head and Neck Surgery recommends documenting resolution, improvement, or worsening of vertigo, tinnitus, and hearing loss after treatment, and obtaining audiograms when assessing patients 11, 12

Management of Ménière's Disease with Conservative and Surgical Approaches

Initial Management and Disease Characteristics

• The American Academy of Otolaryngology-Head and Neck Surgery suggests that Ménière's disease has a naturally fluctuating course with up to 60% placebo response in clinical trials 13

Diagnostic and Monitoring Requirements

• The American Academy of Otolaryngology-Head and Neck Surgery recommends obtaining audiometry at diagnosis and regularly during follow-up to document the characteristic low-to-mid-frequency sensorineural hearing loss and monitor progression 14
• The American Academy of Otolaryngology-Head and Neck Surgery suggests documenting changes in vertigo frequency/severity, tinnitus, and hearing loss after each intervention, and assessing quality of life impact using validated instruments 14

Critical Considerations for Disease Management

• The American Academy of Otolaryngology-Head and Neck Surgery notes that 10-25% of cases eventually become bilateral, which impacts surgical decision-making—avoid ablative procedures in the only hearing ear 14
• The American Academy of Otolaryngology-Head and Neck Surgery warns to watch for drop attacks (Tumarkin's otolithic crisis) in later disease stages, which occur suddenly without warning and without loss of consciousness 14

Treatment of Ménière's Disease with Pharmacotherapy

Maintenance Pharmacotherapy

• The American Academy of Otolaryngology-Head and Neck Surgery suggests titrating down or stopping medications once symptoms subside, as studies show variable treatment windows from 10 days to 24 years 15
• The American Academy of Otolaryngology-Head and Neck Surgery reports that the evidence for betahistine is questionable based on recent high-quality trials, making diuretics the more reliable maintenance option, although the specific details of this trial are not provided in the text, the BEMED trial showed no significant difference versus placebo 15

Treatment NOT Recommended

• The American Academy of Otolaryngology-Head and Neck Surgery does not recommend prescribing positive pressure therapy (Meniett device), as multiple systematic reviews and RCTs show no significant difference compared to placebo for vertigo control, and the device may actually worsen hearing levels based on moderate quality evidence from two studies 15

Evidence‑Based Management of Meniere’s Disease

Dietary and Lifestyle Modifications

• The American Academy of Otolaryngology–Head and Neck Surgery notes that evidence for sodium restriction (1500–2300 mg/day), caffeine avoidance, and alcohol limitation is limited (Grade C), derived mainly from observational studies; no cases of hyponatraemia have been reported when patients receive appropriate nutritional counseling. 16

Pharmacologic Maintenance Therapy

• Diuretics are recommended as the first‑line pharmacologic maintenance therapy for Meniere’s disease, supported by moderate‑quality evidence from observational cohorts and Cochrane systematic reviews that demonstrate reduction in endolymphatic volume. 16

Special Populations & Contra‑indications for Diuretics

• Patients with comorbid renal or cardiac disease should be excluded from diuretic therapy. 16
• In pregnancy, diuretics and intratympanic gentamicin are contraindicated; management should rely on dietary measures and short courses of vestibular suppressants during acute attacks. 16
• For individuals with renal impairment, diuretic dosing should be avoided or adjusted, and intratympanic steroids should be considered earlier in the algorithm. 16
• In hypertensive patients, diuretics may provide dual blood‑pressure control, but electrolyte levels must be monitored closely. 16

Intratympanic Steroid Therapy

• Intratympanic steroid injections are advised for patients whose disease remains active after 3–6 months of conservative measures and diuretics; they achieve vertigo improvement in 85–90 % of cases versus 57–80 % with conventional therapy alone. 16
• Reported adverse effects of intratympanic steroids include hearing loss, tympanic‑membrane perforation, and persistent imbalance, often requiring multiple treatment sessions. 16

Intratympanic Gentamicin Therapy

• Intratympanic gentamicin is reserved for patients with persistent vertigo after failure of lifestyle measures, diuretics, and steroids; it provides complete vertigo control in approximately 73.6 % of treated individuals. 16
• Gentamicin is contraindicated in patients with contralateral vestibular disease or hypofunction and in those with known aminoglycoside hypersensitivity. 16

Therapies Not Recommended

• Positive‑pressure therapy (Meniett device) is not recommended; multiple systematic reviews and randomized controlled trials show no significant benefit over placebo for vertigo control and may even worsen hearing, based on moderate‑quality evidence. 16